NEWARK, Del, April 01, 2024 (GLOBE NEWSWIRE) -- The legionella testing market is anticipated to be valued at US$ 355.1 million by 2024. The market valuation is estimated to be US$ 910 million by 2034, projected at a CAGR of 9.9%.
The legionella testing market is experiencing a surge in awareness of Legionnaires' disease, that is needed to mitigate its risks. Regulatory mandates in various industries, like healthcare, hospitality, and industrial sectors, are driving the demand for legionella testing services.
Advancements in testing technologies, like rapid testing kits and molecular techniques, help in the enhancement, accuracy and efficiency of legionella detection, further fueling the expansion of the market.
Request a Sample of this Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-19279
The expansion into emerging markets, sees growth in awareness of Legionnaires' disease that has limited access to testing services. Testing companies tap into new revenue streams and lead to contribution and improvement in public health outcomes.
Integrating legionella testing services into comprehensive water management programs present an opportunity by enhancing risk mitigation efforts and thus ensure regulatory compliance across various industries.
Several threats pose challenges to the legionella testing market like complexity of testing processes, cost constraints for smaller facilities, and the emergence of new strains of legionella bacteria.
Misinformation or stigma surrounding Legionnaires' disease lead to discouragement of some facilities from proactively testing or disclosing outbreaks, which lead to underreporting and thus hamper prevention efforts.
Key Takeaways from the Legionella Testing Market Study
- Under type, the urine antigen testing (UAT) registered to expand at 9.7% CAGR by 2034.
- The United Kingdom is estimated to register at a CAGR of 11.1% by 2034.
- China experiences significant growth, projected at a CAGR of 10.5% by 2034.
- Based on end user, the clinical laboratories segment is anticipated to expand at 9.5% CAGR by 2034.
“The growth in awareness of Legionnaires' disease and the need for effective risk management strategies is one significant driver for the Legionella Testing market,” comments Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Competitive Landscape from the Legionella Testing Market:
Established players offer a wide a range of testing services and solutions Innovative startups have started leveraging technological advancements to disrupt traditional testing methods.
Competition is majorly fueled by factors such as regulatory compliance, technological innovation, and customer-centricity. Some of the key developments are:
- In December 2021, Pace Analytical Services acquired Special Pathogens Laboratory, a specialist used in Legionella testing, detection, remediation, and prevention.
- In April 2018, Phigenics Research and Innovation Lab introduced the Next Day Legionella PCR test, that leveraged the patented Phigenics Validation Test (PVT) TimeZero method required for rapid detection of Legionella DNA via PCR.
Click Here to Request Methodology! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-19279
Top Companies Profiled from the Legionella Testing Market:
- Quidel Corporation
- Abbott (Alere)
- Merck KGaA
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Pro-lab Diagnostics Inc.
- bioMerieux
- IDEXX Corporation
- Eurofins Scientific
- Beckman Coulter Inc.
More Valuable Insights Available
Future Market Insights offers an unbiased global legionella testing market analysis, providing historical data from 2019 to 2023 and forecast statistics from 2024 to 2034
To understand market opportunities, the legionella testing market is segmented based on Type (Culture Media, Urine Antigen Testing (UAT), Polymerase Chain Reaction (PCR), Serology, Direct Fluorescent Antibody (DFA) Test), End-User (Hospitals & Clinics, Clinical Laboratories, Others) and Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa).
Click Here To Buy Your Full Report! https://www.futuremarketinsights.com/checkout/19279
Legionella Testing Market Key Segments
By Type:
- Culture Media
- Urine Antigen Testing (UAT)
- Polymerase Chain Reaction (PCR)
- Serology
- Direct Fluorescent Antibody (DFA) Test
By End User:
- Hospitals & Clinics
- Clinical Laboratories
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- Middle East and Africa
About the Healthcare Division at Future Market Insights
The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide. With over 100+ reports and one million+ data points, the team has analyzed the industry lucidly in 50+ countries for over a decade. The team briefly analyzes key trends, including competitive landscape, profit margin, and research development efforts.
Have a Look at the Related Report from the Legionella Testing Market:
The global cystatin C testing market was valued at around US$ 194.3 Mn at the end of 2021. The market is projected to register a 7.5% CAGR and top a valuation of US$ 400.4 Mn by 2032.
The legionnaire disease testing market is projected to register a CAGR of 9% during the forecast period, up from US$ 292 Mn in 2022 to reach a valuation of US$ 819.5 Mn by 2032.
global respiratory pathogen testing kits market is expected to record a CAGR of 5.7% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 4,083.1 million. By 2033
global at-home testing market is expected to enjoy a valuation of US$ 7.1 billion in 2022, and further expand at a CAGR of 4.0% to reach a valuation of US$ 10.5 billion by the end of the year 2032.
at-home molecular testing market size is projected to be worth US$ 10.2 billion in 2023. The market is likely to surpass US$ 18.1 billion by 2033 at a CAGR of 5.9% during the forecast period.
global hemostasis testing systems market share is estimated to clock a revenue of US$ 3,666 million by 2033. Our healthcare industry experts opine that hemostasis testing systems providers can expect a CAGR of 5.5% through 2033, with a present valuation of US$ 2,149.3 million in 2023.
global helicobacter pylori non-invasive testing market is projected to register at a moderate-paced CAGR of 4.4% over the forecast period. The helicobacter pylori non-invasive testing market is currently valued at US$ 650.50 Million in 2023. By 2033
The global healthcare interoperability solutions market is forecasted to expand at 14.5% CAGR to reach a market valuation of US$ 16.2 billion by the end of 2033, up from US$ 3.7 billion that was recorded for 2022.
global Healthcare Analytical Testing Services Market was valued at around US$ 11.9 billion in 2021. With a projected CAGR of 14% for the next ten years, the market is likely to reach a valuation of US$ 49.6 billion by the end of 2032.
The global water testing kits market size is expected to surge from US$ 1.9 billion in 2024 to US$ 3.3 billion by 2034. Over the forecast period, global sales of water testing kits are anticipated to soar at a 5.4% CAGR.
Authored by:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
